Idh2tm1Meln
Targeted Allele Detail
|
Symbol: |
Idh2tm1Meln |
Name: |
isocitrate dehydrogenase 2 (NADP+), mitochondrial; targeted mutation 1, Ari Melnick |
MGI ID: |
MGI:5906615 |
Synonyms: |
Idh2R140Q |
Gene: |
Idh2 Location: Chr7:79744594-79765140 bp, - strand Genetic Position: Chr7, 45.43 cM
|
Alliance: |
Idh2tm1Meln page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:241017
|
Parent Cell Line: |
BAC-BA1 (ES Cell)
|
Strain of Origin: |
(C57BL/6 x 129S/SvEv)F1
|
|
Allele Type: |
|
Targeted (Conditional ready, Humanized sequence, Null/knockout) |
Mutations: |
|
Insertion, Single point mutation
|
|
|
Mutation details: A c.419G>A mutation was engineered in exon 4, changing arginine codon 140 into a glutamine codon (p.Arg140Gln). This mutation is found in tumors from human accute myeloid leukemia (AML) patients. A loxP site flanked neomycin resistance gene and stop cassette was inserted into intron 3. This creates a conditional-ready null allele that expresses the mutated protein only after cre-mediated recombination.
(J:241017)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Idh2 Mutation: |
145 strains or lines available
|
|
Original: |
J:241017 Shih AH, et al., Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia. Cancer Discov. 2017 May;7(5):494-505 |
All: |
4 reference(s) |
|